ReflexMD Review
Appears to have shut downReflexMD is closed and is not taking new patients. It charged from $199 a month.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
ReflexMD is no longer taking new patients. This program appears to have shut down, so we're not linking to it. Here are the top-rated GLP-1 providers we recommend instead.
Last published price before it closed: $199/mo. No longer offered.
See our top-rated GLP-1 providers →ReflexMD was a telehealth weight loss seller that offered compounded semaglutide and tirzepatide at flat monthly rates. Its website stopped resolving in July 2026, and the service no longer appears to be operating.
Vetted alternatives to ReflexMD
Collective
Best for: flat any-dose pricing, if you can absorb a $199 annual membership on top
Editorial score · methodology
Embody
Best for: a flat compounded tirzepatide or semaglutide price at every dose, from a seller that names its pharmacies
Editorial score · methodology
Luvo Health
Best for: moving between compounded and brand without changing seller
Editorial score · methodology
ReflexMD at a glance
- Status
- Closed: not taking new patients
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Last published price
- $199/mo (Last price listed before ReflexMD shut down in July 2026.)
- What it included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letters found
How ReflexMD scores
ReflexMD has closed. These scores describe what it published when we last checked it, before it stopped taking patients.
Six columns, each one computed from something ReflexMD published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
5.0/10$199/month is exactly the median for compounded semaglutide across the sellers we compare.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10A price is shown before the questionnaire starts.
Trust & Safety15%
6.5/10No pharmacy is named for its prescriptions. It shows a price before asking for health information.
Accessibility10%
5.0/10No state list is available to check, so this is held at the midpoint rather than scored on reach.
Support10%
7.0/10The price covers the medication, clinician visits and shipping.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on ReflexMD
Last checked June 2026- Checked the listed price across 3 dose or plan tiers
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for ReflexMD
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
Medications ReflexMD listed
ReflexMD listed compounded semaglutide and compounded tirzepatide. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.
Prices it published before closing
Prices re-verified
Last price listed before ReflexMD shut down in July 2026.
Last price listed before ReflexMD shut down in July 2026.
Oral tablets. Last price listed before ReflexMD shut down in July 2026.
In its favor
- Semaglutide cost $199 a month, exactly the $199 median for compounded semaglutide across the sellers we compare
- Tirzepatide cost $297 a month, close to the $269 median for compounded tirzepatide across the sellers we compare
- Showed its price before the medical questionnaire, so you could compare it without handing over health information
- The monthly price included the medication, clinician visits and shipping
- We found no FDA warning letters issued to ReflexMD
- Offered both oral and injectable options, so the format was the patient's choice
Against it
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
ReflexMD is no longer taking new patients. What follows describes the program as it last ran, for anyone comparing it with a seller that is still open.
What ReflexMD charged
ReflexMD charged $199/month.
- Compounded semaglutide: $199/month
- Compounded tirzepatide: $297/month
- Semaglutide: $199/month
For compounded semaglutide, the median across the sellers we compare is $199/month, so ReflexMD's $199 lands mid-market. Price is unlikely to be the deciding factor.
Bodybuilding Health+ dispenses semaglutide and tirzepatide from $179/month, which makes it the fair comparison to run before you commit here.
What ReflexMD dispensed
ReflexMD prescribed semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two molecules with the largest published weight-loss trial programs behind them. What arrives is compounded at a licensed pharmacy, not an approved pen. That is the reason it costs less, and the reason the finished preparation carries no FDA review behind it.
Safety and disclosure
ReflexMD told buyers its price before the medical questionnaire. We found no FDA warning letters issued to ReflexMD. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Our read
ReflexMD is no longer taking new patients, so the choice is among the sellers that are still open. Belle Health is the nearest comparison we review, and worth reading alongside this.
The Bottom Line
ReflexMD is closed and is not taking new patients. It charged from $199 a month.
Where ReflexMD is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these three counts, another seller does better.
- If you need the FDA-approved pen rather than a compounded vial, consider WellMedRx.
- If the standing monthly cost is what decides it, consider Collective (from $59/mo + membership).
- If you want a human checking in, not just a prescription, consider Eden.
If none of these fits, our guide to alternatives to ReflexMD sets more sellers in the same category beside ReflexMD on price, states and what the price includes.
Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this ReflexMD review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of June 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.